Alencar F, Viana P, Zamperini C, Becker A. Patient education and self-care for the management of jaw pain upon awakening: a randomized controlled clinical trial comparing the effectiveness of adding pharmacologic treatment with cyclobenzaprine or tizanidine. J Oral Facial Pain Headache. 2014;28:119-27 pubmed publisher

Di Rago M, Saar E, Rodda L, Turfus S, Kotsos A, Gerostamoulos D, et al. Fast targeted analysis of 132 acidic and neutral drugs and poisons in whole blood using LC-MS/MS. Forensic Sci Int. 2014;243:35-43 pubmed publisher

Bicknell L, Sanches M, Schatte D. Erythema multiforme vs. DRESS syndrome associated with the combined use of lamotrigine and cyclobenzaprine: a case report. Int J Psychiatry Med. 2012;44:305-14 pubmed

Hernandez diaz S, Su Y, Mitchell A, Kelley K, Calafat A, Hauser R. Medications as a potential source of exposure to phthalates among women of childbearing age. Reprod Toxicol. 2013;37:1-5 pubmed publisher

Sheikh M, Kunka C, Ota K. Treatment of levator ani syndrome with cyclobenzaprine. Ann Pharmacother. 2012;46:e29 pubmed publisher

Vanneste S, Figueiredo R, De Ridder D. Treatment of tinnitus with cyclobenzaprine: an open-label study. Int J Clin Pharmacol Ther. 2012;50:338-44 pubmed

Ramadan N, Zaazaa H, Merey H. Microsized graphite sensors for potentiometric determination of cyclobenzaprine hydrochloride in pure powder, tablets, and plasma. J AOAC Int. 2011;94:1807-14 pubmed

Coelho C, Figueiredo R, Frank E, Burger J, Schecklmann M, Landgrebe M, et al. Reduction of tinnitus severity by the centrally acting muscle relaxant cyclobenzaprine: an open-label pilot study. Audiol Neurootol. 2012;17:179-88 pubmed publisher

Thomas R. Sleep as a window into the world of fibromyalgia syndrome. J Rheumatol. 2011;38:2499-500 pubmed publisher

Xiang Y, Zhou L, Qian Z, Peng K, Li D, Chen X, et al. Determination of cyclobenzaprine in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry and its application in a pharmacokinetic study. Biomed Chromatogr. 2012;26:1083-8 pubmed publisher

Bebarta V, MADDRY J, Borys D, Morgan D. Incidence of tricyclic antidepressant-like complications after cyclobenzaprine overdose. Am J Emerg Med. 2012;30:374 pubmed publisher

Borges N, Rezende V, Santana J, Moreira R, Moreira R, Moreno P, et al. Chlorpromazine quantification in human plasma by UPLC-electrospray ionization tandem mass spectrometry. Application to a comparative pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879:3728-34 pubmed publisher

Abernethy D, Bai J, Burkhart K, Xie H, Zhichkin P. Integration of diverse data sources for prediction of adverse drug events. Clin Pharmacol Ther. 2011;90:645-6 pubmed publisher

Mestres J, Seifert S, Oprea T. Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Clin Pharmacol Ther. 2011;90:662-5 pubmed publisher

de Santana Santos T, Calazans A, Martins Filho P, Silva L, de Oliveira e Silva E, Gomes A. Evaluation of the muscle relaxant cyclobenzaprine after third-molar extraction. J Am Dent Assoc. 2011;142:1154-62 pubmed

Moldofsky H, Harris H, Archambault W, Kwong T, LEDERMAN S. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study. J Rheumatol. 2011;38:2653-63 pubmed publisher

Darwish M, Hellriegel E. Steady-state pharmacokinetics of once-daily cyclobenzaprine extended release: a randomized, double-blind, 2-period crossover study in healthy volunteers. Clin Ther. 2011;33:746-53 pubmed publisher

Pedroso J, Braga Neto P, Abrahão A, Rivero R, Abdalla C, Abdala N, et al. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family. Arq Neuropsiquiatr. 2011;69:288-91 pubmed

Landy S, Altman C, Xie F. Time to recovery in patients with acute painful musculoskeletal conditions treated with extended-release or immediate-release cyclobenzaprine. Adv Ther. 2011;28:295-303 pubmed publisher

Carre Pierrat M, Lafoux A, Tanniou G, Chambonnier L, Divet A, Fougerousse F, et al. Pre-clinical study of 21 approved drugs in the mdx mouse. Neuromuscul Disord. 2011;21:313-27 pubmed publisher

Darwish M, Hellriegel E. Pharmacokinetic profile of once-daily cyclobenzaprine extended-release. Expert Opin Drug Metab Toxicol. 2010;6:1425-36 pubmed publisher

Bebarta V, MADDRY J, Borys D, Morgan D. Incidence of tricyclic antidepressant-like complications after cyclobenzaprine overdose. Am J Emerg Med. 2011;29:645-9 pubmed publisher

Weil A, Ruoff G, Nalamachu S, Altman C, Xie F, Taylor D. Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: a pooled analysis. Postgrad Med. 2010;122:158-69 pubmed publisher

Khwaja S, Minnerop M, Singer A. Comparison of ibuprofen, cyclobenzaprine or both in patients with acute cervical strain: a randomized controlled trial. CJEM. 2010;12:39-44 pubmed

Menard Katcher C, Henretig F, Osterhoudt K. A 19-month-old girl with recurrent illness: over the hills and through the woods. Pediatr Emerg Care. 2009;25:869-71 pubmed publisher

Robbins M, Grosberg B. Menstrual-related nummular headache. Cephalalgia. 2010;30:507-8 pubmed publisher

Reuss R, Reuter I, Jauss M, Fischer F, Muller S, Stolz E. Torticollis under cyclobenzaprine. Pharmacology. 2009;84:91-2 pubmed publisher

Leite F, Atallah A, El Dib R, Grossmann E, Januzzi E, Andriolo R, et al. Cyclobenzaprine for the treatment of myofascial pain in adults. Cochrane Database Syst Rev. 2009;:CD006830 pubmed publisher

Gillman P. Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity?. Am J Emerg Med. 2009;27:509-10; author reply 510 pubmed publisher

Toth P, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther. 2004;26:1355-67 pubmed

Kobayashi H, Hasegawa Y, Ono H. Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. Eur J Pharmacol. 1996;311:29-35 pubmed